BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Argenta Discovery Inc. Receives CIR (French Research Tax Credit) Accreditation


11/15/2010 1:56:53 PM

Harlow, UK; 15 November 2010 - Argenta, a service division of Galapagos NV (Euronext: GLPG), announced today that it has received the CIR accreditation from the French Ministry of Higher Education and Research.

The accreditation allows French companies to benefit from significant tax relief (Crédit d'Impôt sur la Recherche) on research carried out by Argenta on their behalf.

Dr. Jeremy Billson, Argenta's VP Business Development, commented: "We are delighted to receive this accreditation from the French Ministry of Research, which will allow our eligible clients to receive tax credits amounting to 30% of their R&D expenditure with Argenta. As such, it should facilitate our efforts to expand Argenta's client base in France."

For further information concerning the Crédit d'Impôt sur la Recherche, please refer to the website of the Ministère de l'Enseignement Supérieur et de la Recherche: http://www.enseignementsup-recherche.gouv.fr

About Argenta

Argenta's contract research, which includes expertise in medicinal chemistry, computer-aided drug discovery, in vitro biology, analytics, in vivo pharmacokinetics, pharmacology and world-leading respiratory models, has a strong reputation for scientific excellence. Argenta was acquired by Galapagos in February 2010 and employs over 140 people in the UK with its main operations in Harlow. More info at: www.argentadiscovery.com

CONTACT

Jeremy Billson, VP Business Development, Argenta Tel: +44 1279 645645 argenta@glpg.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES